Gene · 3269
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The off‑target effect of loratadine triggers autophagy‑mediated apoptosis in lung adenocarcinoma cells by deactivating JNK, p38, and STAT3 signaling through both PP2A‑dependent and independent pathways. | Int J Mol Med | 2025 | 39886963 | PubTator, text mining | PubMed |
| Transformer Decoder Learns from a Pretrained Protein Language Model to Generate Ligands with High Affinity. | J Chem Inf Model | 2025 | 39871540 | PubTator, text mining | PubMed |
| In-silico discovery of efficient second-generation drug derivatives with enhanced antihistamine potency and selectivity. | Comput Biol Chem | 2025 | 39799798 | PubTator, text mining | PubMed |
| Comparison of new secondgeneration H1 receptor blockers with some molecules; a study involving DFT, molecular docking, ADMET, biological target and activity. | BMC Chem | 2025 | 39755645 | PubTator, text mining | PubMed |
| Stimulation of histamine H1-receptors produces a positive inotropic effect in the human atrium. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39729205 | PubTator, text mining | PubMed |
| Probing the Histamine H1 Receptor Binding Site to Explore Ligand Binding Kinetics. | J Med Chem | 2025 | 39723903 | PubTator, text mining | PubMed |
| Histamine receptor agonism differentially induces immune and reparative healing responses in biomaterial-facilitated tissue repair. | Biomaterials | 2025 | 39586217 | PubTator, text mining | PubMed |
| Cetirizine platinum(IV) complexes with antihistamine properties inhibit tumor metastasis by suppressing angiogenesis and boosting immunity. | J Inorg Biochem | 2025 | 39476503 | PubTator, text mining | PubMed |
| Preventive Effect of Hydroxyzine on Postoperative Nausea and Vomiting: A Single-Center, Retrospective, Observational Cohort Study. | J Clin Med | 2024 | 39768731 | PubTator, text mining | PubMed |
| iPSC-derived human sensory neurons reveal a subset of TRPV1 antagonists as anti-pruritic compounds. | Sci Rep | 2024 | 39732807 | PubTator, text mining | PubMed |
| Mast Cells as a Component of Spermatogonial Stem Cells' Microenvironment. | Int J Mol Sci | 2024 | 39684887 | PubTator, text mining | PubMed |
| Changes in Gene Expression Related to Atopic Dermatitis in Mothers and Infants Following VOC Exposure. | Int J Mol Sci | 2024 | 39684538 | PubTator, text mining | PubMed |
| Enhancing immuno-oncology efficacy with H1-antihistamine in cancer therapy: a review of current research and findings. | Curr Med Res Opin | 2024 | 39503414 | PubTator, text mining | PubMed |
| Optical Imaging of Single Extracellular Vesicles: Recent Progress and Prospects. | Chem Biomed Imaging | 2024 | 39473463 | PubTator, text mining | PubMed |
| Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor. | Sci Rep | 2024 | 39462031 | PubTator, text mining | PubMed |
| Histamine H1-receptor-mediated modulation of NMDA receptors signaling responses. | Pharmacol Res Perspect | 2024 | 39376050 | PubTator, text mining | PubMed |
| Opportunities and challenges in the therapeutic exploitation of histamine and histamine receptor pharmacology in inflammation-driven disorders. | Pharmacol Ther | 2024 | 39306197 | PubTator, text mining | PubMed |
| Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer. | Front Oncol | 2024 | 39267843 | PubTator, text mining | PubMed |
| Macrophage Scavenger Receptor 1 attenuates ischemic white matter injury via HRH1-mediated microglial phagocytosis. | Neurosci Lett | 2024 | 39214333 | PubTator, text mining | PubMed |
| The role of heterodimers formed by histamine H3 receptors and dopamine D1 receptors on the methamphetamine-induced conditioned place preference. | Eur J Pharmacol | 2024 | 39089461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3269/papers?page=6